Climate Change Skeptics, Here's a Lesson from Harappan Extinction

Many hypotheses have been floated after many, many years of work on what actually led to the collapse of Harappa, the largest Bronze Age Civilization and the earliest urban civilization that India has seen, some 5200 to 4500 years ago. Some said the invading Aryans destroyed it; others proposed that there were massive earthquakes which […]

Climate Change Skeptics, Here’s a Lesson from Harappan Extinction

Many hypotheses have been floated after many, many years of work on what actually led to the collapse of Harappa, the largest Bronze Age Civilization and the earliest urban civilization that India has seen, some 5200 to 4500 years ago. Some said the invading Aryans destroyed it; others proposed that there were massive earthquakes which […]

Will Facebook (Fiasco) Bring Back Sheen on Other Tech Startups?

To begin with, I am not a disgruntled Facebook investor, several of whom are suing the company, Nasdaq and Morgan Stanley. Ever since the historic opening on Nasdaq last Friday, the brutal analysis of  Facebook’s fall from grace is relentless and writers are tearing apart its management of (social) media strategy, with an opinion piece […]

Philips Wakes up to Reverse Innovation

It was sort of a report-card day for Wido Menhardt, the chief executive of Philips Innovation Centre (PIC) in Bangalore on Friday. A little over two years into this role, he was showcasing some of the technologies and products that were developed “in India, for India”, a tagline that has, frankly speaking, begun to sound […]

Don't be Averse to Clinical Trials, Fix the System

A panel report, as reported in Mint today, shows the much suspected irregularities in the drug controller’s office. This specific committee report is about the drug approval process, but I want to raise a related issue here, of clinical trials. I know, given the herd mentality, a fresh backlash against clinical trials will begin in […]

Don’t be Averse to Clinical Trials, Fix the System

A panel report, as reported in Mint today, shows the much suspected irregularities in the drug controller’s office. This specific committee report is about the drug approval process, but I want to raise a related issue here, of clinical trials. I know, given the herd mentality, a fresh backlash against clinical trials will begin in […]